| Breakdown | TTM | Mar 2025 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 23.39B | 21.91B | 20.28B | 15.54B | 10.19B | 7.36B |
| Gross Profit | 5.19B | 4.91B | 5.45B | 3.63B | 2.39B | 1.96B |
| EBITDA | 1.58B | 1.30B | 2.94B | 2.35B | 1.81B | 1.12B |
| Net Income | 1.36B | 1.10B | 1.93B | 1.66B | 1.26B | 1.05B |
Balance Sheet | ||||||
| Total Assets | 43.64B | 40.93B | 34.96B | 24.95B | 20.79B | 17.46B |
| Cash, Cash Equivalents and Short-Term Investments | 8.19B | 7.73B | 5.40B | 4.78B | 5.03B | 4.97B |
| Total Debt | 10.96B | 10.02B | 7.94B | 3.65B | 3.45B | 3.14B |
| Total Liabilities | 31.13B | 28.75B | 23.42B | 14.85B | 12.00B | 9.61B |
| Stockholders Equity | 12.56B | 12.22B | 11.59B | 10.04B | 8.70B | 7.84B |
Cash Flow | ||||||
| Free Cash Flow | 1.95B | 1.40B | 36.79M | -233.92M | -16.43M | 677.23M |
| Operating Cash Flow | 2.31B | 2.15B | 2.52B | 1.08B | 922.80M | 1.07B |
| Investing Cash Flow | -626.72M | -973.45M | -4.97B | 639.25M | -296.01M | -647.37M |
| Financing Cash Flow | -839.51M | 894.53M | 2.96B | -376.81M | -226.70M | -601.72M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | HK$38.38B | 12.46 | 18.71% | 6.05% | 2.23% | 13.60% | |
71 Outperform | HK$13.78B | 8.98 | 11.08% | 4.26% | 2.60% | 49.21% | |
68 Neutral | HK$38.65B | 4.40 | 11.00% | 3.41% | 15.52% | -23.76% | |
67 Neutral | HK$46.34B | 12.86 | 15.55% | 1.44% | 34.78% | 98.79% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | HK$13.47B | 10.67 | 10.48% | 4.49% | -9.90% | -20.25% | |
61 Neutral | HK$81.81B | 12.43 | 7.45% | 7.28% | -3.92% | 2.33% |